Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Hiemke

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Current Drug Delivery|October 30, 2015
Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and NeurologyChristoph Hiemke
Expert Review of Neurotherapeutics|February 26, 2016
Why do antidepressant therapies have such a poor success rate?Christoph Hiemke
European Journal of Clinical Pharmacology|January 16, 2008
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatryChristoph Hiemke
European Archives of Psychiatry and Clinical Neuroscience|April 12, 2008
Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?Christoph Hiemke
Pharmazie in Unserer Zeit|May 1, 2008
[Individualized treatment with tricyclic antidepressives. The pharmacogenetics of depression]Christoph Hiemke
Therapeutic Drug Monitoring|March 19, 2019
Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference RangesChristoph Hiemke
Acta Neuropsychiatrica|January 24, 2015
Personalised medicine in psychiatry? Yes, but how?Christoph Hiemke
Behavioural Brain Research|July 12, 2002
Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-mazeUlrich Schmitt, Christoph Hiemke
Handbook of Experimental Pharmacology|November 7, 2012
Interactions and monitoring of antipsychotic drugsChristoph Hiemke, Bruno Pfuhlmann
Current Drug Delivery|September 25, 2012
Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatryChristoph Hiemke, Mohamed Shams
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Current Drug Delivery|October 30, 2015
Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and NeurologyChristoph Hiemke
Expert Review of Neurotherapeutics|February 26, 2016
Why do antidepressant therapies have such a poor success rate?Christoph Hiemke
European Journal of Clinical Pharmacology|January 16, 2008
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatryChristoph Hiemke
European Archives of Psychiatry and Clinical Neuroscience|April 12, 2008
Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?Christoph Hiemke
Pharmazie in Unserer Zeit|May 1, 2008
[Individualized treatment with tricyclic antidepressives. The pharmacogenetics of depression]Christoph Hiemke
Therapeutic Drug Monitoring|March 19, 2019
Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference RangesChristoph Hiemke
Acta Neuropsychiatrica|January 24, 2015
Personalised medicine in psychiatry? Yes, but how?Christoph Hiemke
Behavioural Brain Research|July 12, 2002
Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-mazeUlrich Schmitt, Christoph Hiemke
Handbook of Experimental Pharmacology|November 7, 2012
Interactions and monitoring of antipsychotic drugsChristoph Hiemke, Bruno Pfuhlmann
Current Drug Delivery|September 25, 2012
Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatryChristoph Hiemke, Mohamed Shams
Pageof 24